$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Oral pharmaceutical composition through mucosa 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-009/36
  • A61F-009/02
출원번호 US-0870027 (1986-06-03)
우선권정보 GB-0014665 (1985-06-11)
발명자 / 주소
  • Jenkins Anthony W. (Cambridge GBX) Leslie Stewart T. (Cambridge GBX) Miller Ronald B. (Basel CHX)
출원인 / 주소
  • Euroceltique, S.A. (Luxembourg LUX 03)
인용정보 피인용 횟수 : 129  인용 특허 : 5

초록

An arrangement is provided for the application of an oral pharmaceutical to the mucosa of the oral or nasal cavity, for sustained release there of the drug. The arrangement of the invention comprises a body which has a size and shape suitable for insertion into and retention in the oral or nasal cav

대표청구항

Arrangement adapted for application and adherence to the mucosa of the oral or nasal cavity for sustained release there of an orally administerable drug, said arrangement comprising a body having an orally administerable drug distributed therein and having a size and shape suitable for insertion int

이 특허에 인용된 특허 (5)

  1. Hanna Gayda (Berwyn PA) Vadino Winston A. (Bridgewater NJ), Controlled release dosage forms comprising hydroxypropylmethylcellulose.
  2. DeFoney George F. (Philadelphia PA) Mayes Donald S. (Sunbury PA) Brenman Henry S. (Cinnaminson NJ), Long-acting articles for oral delivery and process.
  3. Nagai Tsuneji (Chofu JPX) Machida Yoshiharu (Kawasaki JPX) Suzuki Yoshiki (Hino JPX) Ikura Hiroshi (Hino JPX), Method and preparation for administration to the mucosa of the oral or nasal cavity.
  4. Suzuki Yoshiki (Hino JPX) Ikura Hiroshi (Hino JPX) Yamashita Gentaro (Koganei JPX), Slow-releasing medical preparation to be administered by adhering to a wet mucous surface.
  5. Kigasawa Kazuo (Tokyo JPX) Shimizu Hiroaki (Tokyo JPX) Hayashi Toshihiro (Chiba JPX) Watabe Kazuo (Kanagawa JPX) Tanizaki Akira (Tokyo JPX) Koyama Osamu (Tokyo JPX) Wakisaka Kikuo (Tokyo JPX) Ogawa Y, Soft buccal.

이 특허를 인용한 특허 (129)

  1. Matthews, Frank; Boehm, Garth; Tang, Lijuan; Liang, Alfred, Abuse-deterrent multi-layer pharmaceutical composition comprising an opioid antagonist and an opioid agonist.
  2. Matthews, Frank; Boehm, Garth; Tang, Lijuan; Liang, Alfred, Abuse-deterrent multi-layer pharmaceutical composition comprising an opioid antagonist and an opioid agonist.
  3. Caruso, Frank S.; Kao, Huai-Hung, Abuse-resistant controlled-release opioid dosage form.
  4. Caruso, Frank S.; Kao, Huai-Hung, Abuse-resistant controlled-release opioid dosage form.
  5. Caruso, Frank S.; Kao, Huai-Hung, Abuse-resistant controlled-release opioid dosage form.
  6. Caruso, Frank S.; Kao, Huai-Hung, Abuse-resistant controlled-release opioid dosage form.
  7. Caruso, Frank S.; Kao, Huai-Hung, Abuse-resistant controlled-release opioid dosage form.
  8. Caruso, Frank S.; Kao, Huai-Hung, Abuse-resistant controlled-release opioid dosage form.
  9. Caruso, Frank S.; Kao, Huai-Hung, Abuse-resistant controlled-release opioid dosage form.
  10. Caruso, Frank S.; Kao, Huai-Hung, Abuse-resistant controlled-release opioid dosage form.
  11. Caruso, Frank S.; Kao, Huai-Hung, Abuse-resistant controlled-release opioid dosage form.
  12. Caruso, Frank S.; Kao, Huai-Hung, Abuse-resistant controlled-release opioid dosage form.
  13. Caruso, Frank S.; Kao, Huai-Hung, Abuse-resistant controlled-release opioid dosage form.
  14. Mehta, Atul M., Abuse-resistant oral dosage forms and method of use thereof.
  15. Mehta, Atul M., Abuse-resistant oral dosage forms and method of use thereof.
  16. Mehta, Atul M., Abuse-resistant oral dosage forms and method of use thereof.
  17. Kim, Ji-Young; Kim, Jong-Ho; Chang, Sug-Youn; Yun, Sei-Young; Yang, Hae-Young; Kwak, Sang-Hoon, Apparatus and method for whitening teeth.
  18. Gail K. Buehler ; Frank Bunick, Chewable product.
  19. Von Coburg, Yvonne; Reimer, Karen; Oksche, Alexander; Holzer, Peter, Combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation.
  20. Besse, Jerome, Composition containing hydroxypropylmethylcellulose and/or ethylcellulose as disintegrants and process for producing it.
  21. Odidi, Isa; Odidi, Amina, Controlled extended drug release technology.
  22. Odidi, Isa; Odidi, Amina, Controlled release delivery device comprising an organosol coat.
  23. Baichwal Anand (Wappingers Falls NY) McCall Troy W. (New Milford CT), Controlled release formulation (albuterol).
  24. Baichwal Anand ; McCall Troy W., Controlled release formulation (albuterol).
  25. Fuisz, Richard C.; Fuisz, Joseph M.; Myers, Garry L., Edible water-soluble film containing a foam reducing flavoring agent.
  26. Myers, Garry L.; Fuisz, Richard C., Film compositions for delivery of actives.
  27. Qi, Xiaoyang, Fusogenic properties of saposin C and related proteins and peptides for application to transmembrane drug delivery systems.
  28. Cohen, Irun R.; Zanin-Zhorov, Alexandra; Tal, Guy; Quintana, Francisco; Pevsner, Meirav; Lider, Ofer, HSP60, HSP60 peptides and T cell vaccines for immunomodulation.
  29. Danagher, Helen Kathleen; Hayes, Geoffrey Gerard; Heun, Gerhard Josef; Mohammad, Hassan; Walden, Malcolm; Whitehouse, Jonathon Oliver, Immediate release pharmaceutical compositions comprising oxycodone and naloxone.
  30. Danagher, Helen Kathleen; Hayes, Geoffrey Gerard; Heun, Gerhard Josef; Mohammad, Hassan; Walden, Malcolm; Whitehouse, Jonathon Oliver, Immediate release pharmaceutical compositions comprising oxycodone and naloxone.
  31. Carson,Dennis A.; Cottam,Howard B.; Leoni,Lorenzo M., Indole compounds useful for the treatment of cancer.
  32. Carson,Dennis A.; Cottam,Howard B.; Leoni,Lorenzo M., Indole compounds useful for the treatment of cancer.
  33. Carson,Dennis A.; Leoni,Lorenzo M.; Cottam,Howard B., Indole compounds useful for the treatment of cancer.
  34. Campbell, Phillip, Lesion and ulcer medication.
  35. Brögmann, Bianca; Muhlau, Silke; Spitzley, Christof, Matrix for sustained, invariant and independent release of active compounds.
  36. Brögmann, Bianca; Mühlah, Silke; Spitzley, Christof, Matrix for sustained, invariant and independent release of active compounds.
  37. Brögmann, Bianca; Mühlau, Silke; Spitzley, Christof, Matrix for sustained, invariant and independent release of active compounds.
  38. Leyendecker, Petra; Hopp, Michael; Drews, Axel, Method and device for the assessment of bowel function.
  39. Yang, Robert K.; Fuisz, Richard C.; Myers, Garry L.; Fuisz, Joseph M., Method of making self-supporting therapeutic active-containing film.
  40. Nardella, Francis A., Methods and compositions for the treatment of chronic lymphocytic leukemia.
  41. Arnold, Kristin Anne; Feng, Hengsheng, Methods of use of fenofibric acid.
  42. Arnold, Kristin Anne; Feng, Hengsheng, Methods of use of fenofibric acid.
  43. Arnold, Kristin Anne; Feng, Hengsheng, Methods of use of fenofibric acid.
  44. Kanikanti, Venkata-Rangarao; Rupp, Roland; Brendel, Erich; Weisemann, Claus; Chantraine, Ernst, Multiple unit controlled food effect-independent release pharmaceutical preparations and method for preparing the same.
  45. Schobel, Alexander M.; Myers, Garry L.; Kendall, Keith Joseph; Rademacher, Thomas; Mous, Jan; Barry, Justin N. W.; Williams, Phillip; Barrientos, Africa Garcia, Nanoparticle film delivery systems.
  46. Dam Anders,DKX, Nicotine containing stimulant unit.
  47. Bhagwat Dileep ; Diehl ; II Donald ; Baichwal Anand R., Once-a-day controlled release sulfonylurea formulation.
  48. Bhagwat, Dileep; Baichwal, Anand R.; Diehl, II, Donald, Once-a-day controlled release sulfonylurea formulation.
  49. Bhagwat, Dileep; Diehl, II, Donald; Baichwal, Anand R., Once-a-day controlled release sulfonylurea formulation.
  50. Breder, Christopher; Wright, Curtis; Oshlack, Benjamin, Opiod agonist formulations with releasable and sequestered antagonist.
  51. Kaiko,Robert F.; Colucci,Robert D., Opioid agonist / antagonist combinations.
  52. Breder, Christopher; Wright, Curtis; Oshlack, Benjamin, Opioid agonist formulations with releasable and sequestered antagonist.
  53. Breder, Christopher; Wright, Curtis; Oshlack, Benjamin, Opioid agonist formulations with releasable and sequestered antagonist.
  54. Breder, Christopher; Wright, Curtis; Oshlack, Benjamin, Opioid agonist formulations with releasable and sequestered antagonist.
  55. Kaiko, Robert F.; Colucci, Robert D., Opioid agonist/antagonist combinations.
  56. Kaiko, Robert F.; Colucci, Robert D., Opioid agonist/antagonist combinations.
  57. Kaiko, Robert F.; Colucci, Robert D., Opioid agonist/antagonist combinations.
  58. Kaiko, Robert F.; Colucci, Robert D., Opioid agonist/antagonist combinations.
  59. Kaiko, Robert F.; Colucci, Robert D., Opioid agonist/antagonist combinations.
  60. Kaiko, Robert F.; Colucci, Robert D., Opioid agonist/antagonist combinations.
  61. Kaiko,Robert F.; Colucci,Robert D., Opioid agonist/antagonist combinations.
  62. Fleischer, Wolfgang; Reimer, Karen; Leyendecker, Petra, Opioids for the treatment of the chronic obstructive pulmonary disease (COPD).
  63. Wright, IV, Curtis; Carpanzano, Anthony E., Oral dosage form comprising a therapeutic agent and an adverse-effect agent.
  64. Wright, IV,Curtis; Carpanzano,Anthony E., Oral dosage form comprising a therapeutic agent and an adverse-effect agent.
  65. Odidi, Isa; Odidi, Amina, Oral multi-functional pharmaceutical capsule preparations of proton pump inhibitors.
  66. Kim, Ji-Young; Kim, Jong-Ho; Chang, Sug-Youn; Yun, Sei-Young, Patches for teeth whitening.
  67. Kim, Ji-Young; Kim, Jong-Ho; Chang, Sug-Youn; Yun, Sei-Young, Patches for teeth whitening.
  68. Liang, Alfred; Matthews, Frank; Boehm, Garth; Tang, Lijuan; Johnson, Frank; Stauffer, Joseph, Pharmaceutical composition.
  69. Matthews, Frank; Boehm, Garth; Tang, Lijuan; Liang, Alfred, Pharmaceutical composition.
  70. Odidi, Isa; Odidi, Amina, Pharmaceutical composition having reduced abuse potential.
  71. Matthews, Frank; Boehm, Garth; Tang, Lijuan; Liang, Alfred, Pharmaceutical compositions.
  72. Matthews, Frank; Boehm, Garth; Tang, Lijuan; Liang, Alfred, Pharmaceutical compositions for the deterrence and/or prevention of abuse.
  73. Brögmann, Bianca; Mühlau, Silke; Spitzley, Christof, Pharmaceutical preparation containing oxycodone and naloxone.
  74. Brögmann, Bianca; Mühlau, Silke; Spitzley, Christof, Pharmaceutical preparation containing oxycodone and naloxone.
  75. Oshlack, Benjamin; Van Buskirk, Glenn; Chasin, Mark; Huang, Hua-Pin; Vashi, Vijay, Pharmaceutical product comprising a sequestered agent.
  76. Oshlack, Benjamin; Van Buskirk, Glenn; Chasin, Mark; Huang, Hua-Pin; Vashi, Vijay, Pharmaceutical products.
  77. Yang, Robert K.; Fuisz, Richard C.; Myers, Garry L.; Fuisz, Joseph M., Polyethylene oxide-based films and drug delivery systems made therefrom.
  78. Yang, Robert K.; Fuisz, Richard C.; Myers, Gary L.; Fuisz, Joseph M., Polyethylene oxide-based films and drug delivery systems made therefrom.
  79. Yang, Robert K.; Fuiz, Richard C.; Myers, Garry L.; Fuiz, Joseph M., Process for making a film having a substantially uniform distribution of components.
  80. Yang,Robert K.; Fuisz,Richard C.; Myers,Gary L.; Fuisz,Joseph M., Process for making an ingestible film.
  81. Yang, Robert K.; Fuisz, Richard C.; Myers, Garry L.; Fuisz, Joseph M., Process for manufacturing a resulting multi-layer pharmaceutical film.
  82. Yang, Robert K.; Fuisz, Richard C.; Myers, Garry L.; Fuisz, Joseph M., Process for manufacturing a resulting multi-layer pharmaceutical film.
  83. Yang, Robert K.; Fuisz, Richard C.; Myers, Garry L.; Fuisz, Joseph M., Process for manufacturing a resulting pharmaceutical film.
  84. Odidi, Isa; Odidi, Amina, Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient.
  85. Odidi, Isa; Odidi, Amina, Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient.
  86. Odidi, Isa; Odidi, Amina, Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems.
  87. Qi, Xiaoyang, Saposin C-DOPS: a novel anti-tumor agent.
  88. Qi, Xiaoyang, Saposin C-DOPS: a novel anti-tumor agent.
  89. Breder, Christopher; Oshlack, Benjamin; Wright, Curtis, Sequestered antagonist formulations.
  90. Breder, Christopher; Oshlack, Benjamin; Wright, Curtis, Sequestered antagonist formulations.
  91. Boehm, Garth, Sequestering subunit and related compositions and methods.
  92. Boehm, Garth, Sequestering subunit and related compositions and methods.
  93. Myers, Garry L.; Hilbert, Samuel D.; Boone, Bill J.; Bogue, B. Arlie; Sanghvi, Pradeep; Hariharan, Madhusudan, Sublingual and buccal film compositions.
  94. Myers, Garry L.; Hilbert, Samuel D.; Boone, Bill J.; Bogue, B. Arlie; Sanghvi, Pradeep; Hariharan, Madhusudan, Sublingual and buccal film compositions.
  95. Myers, Garry L.; Hilbert, Samuel D.; Boone, Bill J.; Bogue, Beuford Arlie; Sanghvi, Pradeep; Hariharan, Madhusudan, Sublingual and buccal film compositions.
  96. Weiner, Howard L.; Maron, Ruth; Libby, Peter, Suppression of vascular disorders by mucosal administration of heat shock protein peptides.
  97. Baichwal Anand R., Sustained release heterodisperse hydrogel systems for insoluble drugs.
  98. Baichwal, Anand R., Sustained release heterodisperse hydrogel systems for insoluble drugs.
  99. Baichwal Anand, Sustained release heterodisperse hydrogel systems-amorphous drugs.
  100. Baichwal Anand, Sustained release heterodisperse hydrogel systems-amorphous drugs.
  101. Baichwal Anand R., Sustained release matrix for high-dose insoluble drugs.
  102. Baichwal Anand R., Sustained release matrix for high-dose insoluble drugs.
  103. Baichwal, Anand R., Sustained release matrix for high-dose insoluble drugs.
  104. Baichwal, Anand R.; McCall, Troy W.; Liu, Lirong; Labudzinski, Steve, Sustained release matrix systems for highly soluble drugs.
  105. Oshlack, Benjamin; Wright, Curtis; Haddox, J. David, Tamper resistant oral opioid agonist formulations.
  106. Oshlack, Benjamin; Wright, Curtis; Haddox, J. David, Tamper-resistant oral opioid agonist formulations.
  107. Oshlack, Benjamin; Wright, Curtis; Haddox, J. David, Tamper-resistant oral opioid agonist formulations.
  108. Oshlack, Benjamin; Wright, Curtis; Haddox, J. David, Tamper-resistant oral opioid agonist formulations.
  109. Oshlack, Benjamin; Wright, Curtis; Haddox, J. David, Tamper-resistant oral opioid agonist formulations.
  110. Oshlack, Benjamin; Wright, Curtis; Haddox, J. David, Tamper-resistant oral opioid agonist formulations.
  111. Oshlack, Benjamin; Wright, Curtis; Haddox, J. David, Tamper-resistant oral opioid agonist formulations.
  112. Oshlack, Benjamin; Wright, Curtis; Haddox, J. David, Tamper-resistant oral opioid agonist formulations.
  113. Oshlack, Benjamin; Wright, Curtis; Haddox, J. David, Tamper-resistant oral opioid agonist formulations.
  114. Oshlack, Benjamin; Wright, Curtis; Haddox, J. David, Tamper-resistant oral opioid agonist formulations.
  115. Oshlack, Benjamin; Wright, Curtis; Haddox, J.David, Tamper-resistant oral opioid agonist formulations.
  116. Oshlack, Benjamin; Wright, Curtis; Haddox, J.David, Tamper-resistant oral opioid agonist formulations.
  117. Oshlack, Benjamin; Wright, Curtis; Haddox, J.David, Tamper-resistant oral opioid agonist formulations.
  118. Yang, Robert K.; Fuisz, Richard C.; Myers, Garry L.; Fuisz, Joseph M., Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom.
  119. Yang, Robert K.; Fuisz, Richard C.; Myers, Garry L.; Fuisz, Joseph M., Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom.
  120. Yang,Robert K.; Fuisz,Richard C.; Myers,Gary L.; Fuisz,Joseph M., Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom.
  121. Yang, Robert K.; Fuisz, Richard C.; Myers, Garry L.; Fuisz, Joseph M., Uniform films for rapid dissolve dosage form incorporating taste-masking compositions.
  122. Yang, Robert K.; Fuisz, Richard C.; Myers, Garry L.; Fuisz, Joseph M., Uniform films for rapid dissolve dosage form incorporating taste-masking compositions.
  123. Yang, Robert K.; Fuisz, Richard C.; Myers, Garry L.; Fuisz, Joseph M., Uniform films for rapid dissolve dosage form incorporating taste-masking compositions.
  124. Myers, Garry L.; Sanghvi, Pradeep; Verrall, Andrew Philip; Francis, Vimala; Brooks, Laura, Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions.
  125. Myers, Garry L.; Sanghvi, Pradeep; Verrall, Andrew Philip; Francis, Vimala; Moss, Laura, Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions.
  126. Carson,Dennis A.; Cottam,Howard B.; Adachi,Soichi; Leoni,Lorenzo M., Use of etodolac for the treatment of chronic lymphocytic leukemia.
  127. Carson,Dennis A.; Cottam,Howard B.; Adachi,Souchi; Leoni,Lorenzo M., Use of etodolac for the treatment of prostate cancer.
  128. Carson,Dennis A.; Cottam,Howard B.; Adachi,Souchi; Leoni,Lorenzo M., Use of etodolac in the treatment of multiple myeloma.
  129. Carson,Dennis A.; Leoni,Lorenzo M.; Corr,Mary Patricia, Use of etodolac to treat hyperplasia.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로